| 000 | 01719 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250514225521.0 | ||
| 264 | 0 | _c20051129 | |
| 008 | 200511s 0 0 eng d | ||
| 022 | _a0893-133X | ||
| 024 | 7 |
_a10.1038/sj.npp.1300749 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHenry, Michael E | |
| 245 | 0 | 0 |
_aA comparison of brain and serum pharmacokinetics of R-fluoxetine and racemic fluoxetine: A 19-F MRS study. _h[electronic resource] |
| 260 |
_bNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology _cAug 2005 |
||
| 300 |
_a1576-83 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aBrain _xmetabolism |
| 650 | 0 | 4 | _aBrain Chemistry |
| 650 | 0 | 4 |
_aCytochrome P-450 Enzyme System _xgenetics |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 |
_aFluoxetine _xblood |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMagnetic Resonance Spectroscopy |
| 650 | 0 | 4 |
_aSelective Serotonin Reuptake Inhibitors _xblood |
| 650 | 0 | 4 | _aStereoisomerism |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTissue Distribution |
| 700 | 1 | _aSchmidt, Mark E | |
| 700 | 1 | _aHennen, John | |
| 700 | 1 | _aVillafuerte, Rosemond A | |
| 700 | 1 | _aButman, Michelle L | |
| 700 | 1 | _aTran, Pierre | |
| 700 | 1 | _aKerner, Lynn T | |
| 700 | 1 | _aCohen, Bruce | |
| 700 | 1 | _aRenshaw, Perry F | |
| 773 | 0 |
_tNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology _gvol. 30 _gno. 8 _gp. 1576-83 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/sj.npp.1300749 _zAvailable from publisher's website |
| 999 |
_c15549645 _d15549645 |
||